ArticlePloS one2019

The cost-effectiveness of controlling cervical cancer using a new 9-valent human papillomavirus vaccine among school-aged girls in Australia.

Rashidul Alam Mahumud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.